Matinas Biopharma (MTNB) Stock Chart & Stock Price History $0.56 +0.02 (+3.15%) As of 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsOwnershipSEC FilingsShort InterestBuy This Stock Matinas Biopharma Stock Price Performance The Matinas Biopharma (MTNB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 26.81%, with a year-to-date return of -4.95%. In the past month, the stock has increased 11.40%, reflecting recent market activity. As of the latest close, Matinas Biopharma traded at $0.54 with a market cap of $3.46 million and volume of 41,451 shares. Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.64%1 Month Performance+11.40%3 Month Performance-12.97%Year-To-Date Performance-4.95%1 Year Performance-26.81% MTNB Stock Chart for Tuesday, May, 19, 2026 MTNB Chart by TradingView Matinas Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/19/2026$0.54$0.56+3.15%$0.77$0.486.25 million shs$3.57 million05/18/2026$0.56$0.54-3.74%$0.59$0.5341,451 shs$3.46 million05/15/2026$0.57$0.56-1.94%$0.60$0.5638,706 shs$3.60 million05/14/2026$0.56$0.57+1.44%$0.58$0.5611,813 shs$3.67 million05/13/2026$0.59$0.56-4.41%$0.59$0.5635,668 shs$3.62 million05/12/2026$0.64$0.59-7.84%$0.64$0.5974,883 shs$3.78 million05/11/2026$0.64$0.64+0.34%$0.67$0.6026,432 shs$4.10 million05/08/2026$0.65$0.64-1.09%$0.64$0.5616,345 shs$4.13 million05/07/2026$0.68$0.65-5.15%$0.67$0.6416,734 shs$4.13 million05/06/2026$0.65$0.68+4.45%$0.70$0.6644,041 shs$4.36 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/05/2026N/A$0.65$0.70$0.6520,919 shs$4.17 million04/30/2026$0.61$0.65+6.10%$0.67$0.5856,926 shs$4.17 million04/29/2026$0.60$0.61+2.87%$0.62$0.5932,349 shs$3.93 million04/28/2026$0.61$0.60-2.31%$0.61$0.606,490 shs$3.82 million04/27/2026$0.61$0.61$0.62$0.5721,798 shs$3.91 million04/24/2026$0.62$0.61-1.13%$0.62$0.6022,039 shs$3.91 million04/23/2026$0.56$0.62+10.14%$0.63$0.5765,685 shs$3.96 million04/22/2026$0.55$0.56+1.84%$0.57$0.5619,042 shs$3.59 million04/21/2026$0.55$0.55+0.20%$0.57$0.5530,321 shs$3.53 million04/20/2026$0.50$0.55+9.80%$0.56$0.4979,508 shs$3.52 million Related Companies INAB Stock Price Chart APLT Stock Price Chart CVKD Stock Price Chart LIAN Stock Price Chart MAAQ Stock Price Chart ZIVO Stock Price Chart LEXX Stock Price Chart GNTA Stock Price Chart HOOK Stock Price Chart INTI Stock Price Chart Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:MTNB) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Matinas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
